Cargando…

Generation and Functional Characterization of Anti-CD19 Chimeric Antigen Receptor-Natural Killer Cells from Human Induced Pluripotent Stem Cells

Natural killer (NK) cells are a part of innate immunity that can be activated rapidly in response to malignant transformed cells without prior sensitization. Engineering NK cells to express chimeric antigen receptors (CARs) allows them to be directed against corresponding target tumor antigens. CAR-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klaihmon, Phatchanat, Kang, Xing, Issaragrisil, Surapol, Luanpitpong, Sudjit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341790/ https://www.ncbi.nlm.nih.gov/pubmed/37445684 http://dx.doi.org/10.3390/ijms241310508

Ejemplares similares

Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
por: Klaihmon, Phatchanat, et al.
Publicado: (2023)

Selective Cytotoxicity of Single and Dual Anti-CD19 and Anti-CD138 Chimeric Antigen Receptor-Natural Killer Cells against Hematologic Malignancies
por: Luanpitpong, Sudjit, et al.
Publicado: (2021)

Distinctive Roles of YAP and TAZ in Human Endothelial Progenitor Cells Growth and Functions
por: Klaihmon, Phatchanat, et al.
Publicado: (2022)

Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells
por: Laowtammathron, Chuti, et al.
Publicado: (2023)

Deciphering the Elevated Lipid via CD36 in Mantle Cell Lymphoma with Bortezomib Resistance Using Synchrotron-Based Fourier Transform Infrared Spectroscopy of Single Cells
por: Luanpitpong, Sudjit, et al.
Publicado: (2019)

Metabolic sensor O‐GlcNAcylation regulates megakaryopoiesis and thrombopoiesis through c‐Myc stabilization and integrin perturbation
por: Luanpitpong, Sudjit, et al.
Publicado: (2021)

Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies
por: Pratumkaew, Ponthip, et al.
Publicado: (2021)

Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
por: Angsutararux, Paweorn, et al.
Publicado: (2015)

A novel E-cadherin/SOX9 axis regulates cancer stem cells in multiple myeloma by activating Akt and MAPK pathways
por: Samart, Parinya, et al.
Publicado: (2022)

O-GlcNAcylation homeostasis controlled by calcium influx channels regulates multiple myeloma dissemination
por: Samart, Parinya, et al.
Publicado: (2021)

Musashi-2 in cancer-associated fibroblasts promotes non-small cell lung cancer metastasis through paracrine IL-6-driven epithelial-mesenchymal transition
por: Samart, Parinya, et al.
Publicado: (2023)

Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma
por: Luanpitpong, Sudjit, et al.
Publicado: (2022)

YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation
por: Damkham, Nattaya, et al.
Publicado: (2022)

Correction: Metabolic sensor O-GlcNAcylation regulates erythroid differentiation and globin production via BCL11A
por: Luanpitpong, Sudjit, et al.
Publicado: (2022)

Metabolic sensor O-GlcNAcylation regulates erythroid differentiation and globin production via BCL11A
por: Luanpitpong, Sudjit, et al.
Publicado: (2022)

Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma
por: Luanpitpong, Sudjit, et al.
Publicado: (2017)

Effect of YAP/TAZ on megakaryocyte differentiation and platelet production
por: Lorthongpanich, Chanchao, et al.
Publicado: (2020)

Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status
por: Poohadsuan, Jirarat, et al.
Publicado: (2023)

Induction of cancer-associated fibroblast-like cells by carbon nanotubes dictates its tumorigenicity
por: Luanpitpong, Sudjit, et al.
Publicado: (2016)

A novel TRPM7/O-GlcNAc axis mediates tumour cell motility and metastasis by stabilising c-Myc and caveolin-1 in lung carcinoma
por: Luanpitpong, Sudjit, et al.
Publicado: (2020)

Effect of alternan versus chitosan on the biological properties of human mesenchymal stem cells
por: Charoenwongpaiboon, Thanapon, et al.
Publicado: (2019)

Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
por: Hermanson, David L., et al.
Publicado: (2015)

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
por: Mehta, Rohtesh S., et al.
Publicado: (2018)

Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
por: Yilmaz, Ahmet, et al.
Publicado: (2020)

Chimeric antigen receptor engineered natural killer cells for cancer therapy
por: Zhang, Yalan, et al.
Publicado: (2023)

Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
por: Dai, Kai, et al.
Publicado: (2021)

Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy
por: Wang, Yan, et al.
Publicado: (2023)

Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells
por: Reighard, Seth D., et al.
Publicado: (2020)

2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
por: Xu, Yingxi, et al.
Publicado: (2019)

Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma
por: Poels, Renée, et al.
Publicado: (2021)

Editorial: Adult stem cells for regenerative medicine: From cell fate to clinical applications
por: Li, Jingting, et al.
Publicado: (2022)

Non–clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell‐derived anti–glypican‐3 chimeric antigen receptor‐expressing natural killer/innate lymphoid cells
por: Ueda, Tatsuki, et al.
Publicado: (2020)

Enhanced Cytotoxicity of Natural Killer Cells following the Acquisition of Chimeric Antigen Receptors through Trogocytosis
por: Cho, Fu-Nan, et al.
Publicado: (2014)

Chimeric antigen receptor-natural killer cells: Novel insight into immunotherapy for solid tumors (Review)
por: Peng, Xiaobo, et al.
Publicado: (2021)

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
por: Gong, Ying, et al.
Publicado: (2021)

SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma
por: Luanpitpong, Sudjit, et al.
Publicado: (2015)

Purinergic targeting enhances immunotherapy of CD73(+) solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
por: Wang, Jiao, et al.
Publicado: (2018)

Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of Na(V)1.5 sodium channels
por: de la Roche, Jeanne, et al.
Publicado: (2019)

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
por: Zhang, Jianguang, et al.
Publicado: (2019)

Role of YAP as a Mechanosensing Molecule in Stem Cells and Stem Cell-Derived Hematopoietic Cells
por: Damkham, Nattaya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tk0qp9ejgs3dud8cit0c861a69